Atlas Trials

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

Clinical trial NCT01639521 · WITHDRAWN

Trial details

NCT number
NCT01639521
Sponsor
University of Southern California
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Anterior Urethral CancerLocalized Transitional Cell Cancer of the Renal Pelvis and UreterPosterior Urethral CancerRecurrent Bladder CancerRecurrent Urethral CancerRegional Transitional Cell Cancer of the Renal Pelvis and UreterStage III Bladder CancerTransitional Cell Carcinoma of the BladderUreter CancerUrethral Cancer Associated With Invasive Bladder Cancer
Start date
2013-05-01
Primary completion
2013-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.